The wide array of peripheral arterial diseases (PAD) includes stenosis of the
subclavian artery. Estimated around 2percent of the total population is
thought to have subclavian artery, which is the incidence of subclavian artery
stenosis. Individualsmore than 70 years of age have a 15% prevalence of PAD.
Five percent of patients will have critical limb ischemia out of this group and
roughly a quarter of them will need revascularization. Left subclavian artery
stenosis affects almost fifty percent of patients with documented peripheral
arterial disease, accounting for 30% of all cases. Due to the sluggish course of
the disease, a large population of individuals is asymptomatic. Once the vessel
diameter has shrunk by 50% at the luminal end, symptoms frequently start to
show. The disease is most prevalent in the sixth to seventh decade of life, with
symptoms ranging from central nervous system to the circulatory system
including pain, swelling, numbness, ischemic changes and vertigo to name a
few. The primary method for diagnosing and treating sympathetically
sustained pain disorders involving the upper extremities, such as complicated
regional pain syndrome, is stellate ganglion block, a minimally invasive
operation (CRPS). The stellate ganglion block can be a great treatment
modality in multiple neuropathic pain disorders, including ischemic
neuropathies, painfulviral infections such as herpes zoster (shingles), early
PHN and post-radiation neuritis, where it has been found effective in pain
relief.
Keywords: PHN, CRPS, ischemia, Subclavian Artery Stenosis